Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Mohamed A. Salem, Samir Y. Abbas, Mohamed H. Helal & Abdullah Y. Alzahrani. (2023) Synthesis and Biological Evaluation of Chromen-2-One and Chromen-2-Imine Derivatives Bearing Aryldiazenyl Moiety as Expected Antimicrobial Agents. Polycyclic Aromatic Compounds 43:2, pages 1081-1091.
Read now
Read now
Jayashree V. Patil, Shweta Umar, Rina Soni, Shubhangi S. Soman & Suresh Balakrishnan. (2023) Design, synthesis and anticancer activity of amide derivatives of substituted 3-methyl-benzofuran-2-carboxylic acid. Synthetic Communications 53:3, pages 217-233.
Read now
Read now
Articles from other publishers (11)
Reihane Ghomashi, Shakila Ghomashi, Hamidreza Aghaei, Samineh Massah & Ahmad Reza Massah. (2023) Recent Advances in Biological Active Sulfonamide based Hybrid
Compounds Part C: Multicomponent Sulfonamide Hybrids. Current Medicinal Chemistry 30:37, pages 4181-4255.
Crossref
Crossref
Metin Yildirim, Samet Poyraz & Mehmet Ersatir. (2023) Recent advances on biologically active coumarin-based hybrid compounds. Medicinal Chemistry Research 32:4, pages 617-642.
Crossref
Crossref
Monalisa Mahapatra, Suman K. Mekap, Suvadeep Mal, Jyotirmaya Sahoo, Sanjeeb K. Sahoo & Sudhir K. Paidesetty. (2023)
Coumaryl‐sulfonamide moiety: Unraveling their synthetic strategy and specificity toward
h
CA IX/XII, facilitating anticancer drug development
. Archiv der Pharmazie 356:4.
Crossref
Crossref
Chander, Monika, Akhilesh Kumar, Deepansh Sharma, Pawan K. Sharma & Sita Ram. (2023) Novel benzenesulfonamide bearing 1,2,4-triazoles as potent anti-microbial and anti-oxidant agents. Medicinal Chemistry Research.
Crossref
Crossref
Baji Baba Shaik, Naresh Kumar Katari, Pule Seboletswe, Rambabu Gundla, Narva Deshwar Kushwaha, Vishal Kumar, Parvesh Singh, Rajshekhar Karpoormath & Muhammad D. Bala. (2023) Recent Literature Review on Coumarin Hybrids as Potential Anticancer Agents. Anti-Cancer Agents in Medicinal Chemistry 23:2, pages 142-163.
Crossref
Crossref
Laila Rubab, Sumbal Afroz, Sajjad Ahmad, Saddam Hussain, Iram Nawaz, Ali Irfan, Fozia Batool, Katarzyna Kotwica-Mojzych & Mariusz Mojzych. (2022) An Update on Synthesis of Coumarin Sulfonamides as Enzyme Inhibitors and Anticancer Agents. Molecules 27:5, pages 1604.
Crossref
Crossref
Farzaneh Aminarshad, Shima Heidari, Neda Mostajeran & Ahmad Reza Massah. (2021) Design, solvent-free synthesis and antibacterial activity evaluation of new coumarin sulfonamides. Journal of the Iranian Chemical Society 19:2, pages 547-562.
Crossref
Crossref
Charalampos Kamoutsis, Maria Fesatidou, Anthi Petrou, Athina Geronikaki, Vladimir Poroikov, Marija Ivanov, Marina Soković, Ana Ćirić, Alejandro Carazo & Přemysl Mladěnka. (2021) Triazolo Based-Thiadiazole Derivatives. Synthesis, Biological Evaluation and Molecular Docking Studies. Antibiotics 10:7, pages 804.
Crossref
Crossref
Mehtap Tugrak, Halise Inci Gul, Hulya Akincioglu & Ilhami Gulcin. (2021) New Chalcone Derivatives with Pyrazole and Sulfonamide Pharmacophores as Carbonic Anhydrase Inhibitors. Letters in Drug Design & Discovery 18:2, pages 191-198.
Crossref
Crossref
Akhilesh Kumar Maurya, Viswajit Mulpuru & Nidhi Mishra. (2020) Discovery of Novel Coumarin Analogs against the α-Glucosidase Protein Target of Diabetes Mellitus: Pharmacophore-Based QSAR, Docking, and Molecular Dynamics Simulation Studies. ACS Omega 5:50, pages 32234-32249.
Crossref
Crossref
Samridhi Thakral, Rakesh Narang, Manoj Kumar & Vikramjeet Singh. (2020) Synthesis, molecular docking and molecular dynamic simulation studies of 2-chloro-5-[(4-chlorophenyl)sulfamoyl]-N-(alkyl/aryl)-4-nitrobenzamide derivatives as antidiabetic agents. BMC Chemistry 14:1.
Crossref
Crossref